Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

109 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of Low-Level Laser Therapy for Oral Mucositis in Hematologic Patients Undergoing Transplantation: A Single-Arm Prospective Study.
Nishi H, Horikoshi S, Ohta K, Yoshida T, Fukushima N, Oshita K, Munenaga S, Edahiro T, Ureshino H, Shigeishi H, Yoshioka Y, Konishi M, Ide N, Ogawa Y, Marukawa R, Shintani T, Ino N, Kajiya M, Kakimoto N, Ohge H, Ichinohe T, Kawaguchi H. Nishi H, et al. Among authors: ureshino h. J Pers Med. 2023 Nov 13;13(11):1603. doi: 10.3390/jpm13111603. J Pers Med. 2023. PMID: 38003918 Free PMC article.
Primary effusion lymphoma-like lymphoma with a T cell phenotype.
Kobayashi T, Mori D, Ureshino H, Kido S, Ikeda S, Kimura S, Lefor AK, Matsuishi E. Kobayashi T, et al. Among authors: ureshino h. Ann Hematol. 2018 Apr;97(4):717-718. doi: 10.1007/s00277-017-3200-x. Epub 2017 Dec 4. Ann Hematol. 2018. PMID: 29199356 No abstract available.
Late graft failure with donor-derived GPI-deficient cells in a mixed chimera following allogeneic bone marrow transplantation for severe aplastic anemia.
Katsuya H, Yamaguchi K, Dung TC, Sano H, Itamura H, Okamoto S, Yoshimura M, Ureshino H, Ando T, Zaimoku Y, Nakao S, Kimura S. Katsuya H, et al. Among authors: ureshino h. Bone Marrow Transplant. 2023 Apr;58(4):465-468. doi: 10.1038/s41409-023-01923-7. Epub 2023 Jan 21. Bone Marrow Transplant. 2023. PMID: 36681774 No abstract available.
Dual targeting of aberrant DNA and histone methylation synergistically suppresses tumor cell growth in ATL.
Kurahashi Y, Watanabe T, Yamamoto Y, Ureshino H, Kamachi K, Yoshida-Sakai N, Fukuda-Kurahashi Y, Yamashita S, Hattori N, Nakamura H, Kawaguchi A, Ushijima T, Sueoka E, Kimura S. Kurahashi Y, et al. Among authors: ureshino h. Blood Adv. 2023 Apr 25;7(8):1545-1559. doi: 10.1182/bloodadvances.2022008362. Blood Adv. 2023. PMID: 36516085 Free PMC article.
Targeting aberrant DNA hypermethylation as a driver of ATL leukemogenesis by using the new oral demethylating agent OR-2100.
Watanabe T, Yamashita S, Ureshino H, Kamachi K, Kurahashi Y, Fukuda-Kurahashi Y, Yoshida N, Hattori N, Nakamura H, Sato A, Kawaguchi A, Sueoka-Aragane N, Kojima K, Okada S, Ushijima T, Kimura S, Sueoka E. Watanabe T, et al. Among authors: ureshino h. Blood. 2020 Aug 13;136(7):871-884. doi: 10.1182/blood.2019003084. Blood. 2020. PMID: 32391874 Free article.
Dasatinib-Blinatumomab for Ph-Positive ALL.
Kamachi K, Ureshino H. Kamachi K, et al. Among authors: ureshino h. N Engl J Med. 2021 Jan 28;384(4):384. doi: 10.1056/NEJMc2033785. N Engl J Med. 2021. PMID: 33503351 No abstract available.
109 results